ESTABLISHMENT OF A KNOCKDOWN MODEL FOR UNRAVELLING THE PATHOGENESIS OF MANTLE CELL LYMPHOMA

Autor: Simone Valentin Hansen, Oriane Cédile, Mh, Hansen, Jacob Haaber Christensen, Li Chen, Moustapha Kassem, Niels Abildgaard, Charlotte Guldborg Nyvold

Publikováno v: Valentin Hansen, S, Cédile, O, Hansen, M C, Christensen, J H, Chen, L, Kassem, M, Abildgaard, N & Nyvold, C G 2019, ' ESTABLISHMENT OF A KNOCKDOWN MODEL FOR UNRAVELLING THE PATHOGENESIS OF MANTLE CELL LYMPHOMA ', 24th European Hematology Association Congress (EHA), Amsterdam, Netherlands, 13/06/2019-16/06/2019 . < https://library.ehaweb.org/eha/2019/24th/268004/simone.valentin.hansen.establishment.of.a.knockdown.model.for.unravelling.the.html?f=listing%3D0%2Abrowseby%3D8%2Asortby%3D1%2Asearch%3DESTABLISHMENT+OF+A+KNOCKDOWN+MODEL+FOR+UNRAVELLING+THE+PATHOGENESIS+OF+MANTLE+CELL+LYMPHOMA >
University of Southern Denmark

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::c52e6f29c9d9389e8cc8d43b57c4c77c

Whole Genome Amplification and Exome Sequencing at the Single Cell Level

Autor: Peter Hokland, Anita Tranberg Simonsen, Mh, Hansen, Johnny Hindkjær, Anni Aggerholm

Publikováno v: Aarhus University

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::160eb4d79126d9cf88df5d2617a19672
https://pure.au.dk/portal/en/publications/whole-genome-amplification-and-exome-sequencing-at-the-single-cell-level(cc989146-9354-4666-92bf-66d9a7198188).html

META-ANALYSIS OF LOW ALLELIC BURDEN C481 BTK-MUTATIONS CALLS FOR CAUTION IN IBRUTINIB RESISTANCE EVALUATION

Autor: Mh, Hansen, Sólja Remisdóttir Veyhe, Niels Abildgaard, Charlotte Guldborg Nyvold, Henrik Frederiksen

Publikováno v: University of Southern Denmark

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::31a3561c06c9f3a795ab59712998d551
https://portal.findresearcher.sdu.dk/en/publications/8bf8882c-a3f4-45da-8a48-027375ed20ee

Amiloride lowers plasma TNF and interleukin-6 but not interleukin-17A in patients with hypertension and type 2 diabetes.

Autor: Thangaraj SS; Department of Cardiovascular and Renal Research, Institute for Molecular Medicine, University of Southern Denmark, Odense, Denmark., Oxlund CS; Department of Cardiology, Hospital of Southwest Jutland, Esbjerg, Denmark., Andersen H; Department of Cardiovascular and Renal Research, Institute for Molecular Medicine, University of Southern Denmark, Odense, Denmark., Svenningsen P; Department of Cardiovascular and Renal Research, Institute for Molecular Medicine, University of Southern Denmark, Odense, Denmark., Stubbe J; Department of Cardiovascular and Renal Research, Institute for Molecular Medicine, University of Southern Denmark, Odense, Denmark., Palarasah Y; Department of Cancer and Inflammation Research, Institute for Molecular Medicine, University of Southern Denmark, Odense, Denmark., Fonseca MPD; Department of Cardiovascular and Renal Research, Institute for Molecular Medicine, University of Southern Denmark, Odense, Denmark., Ketelhuth DFJ; Department of Cardiovascular and Renal Research, Institute for Molecular Medicine, University of Southern Denmark, Odense, Denmark., Enggaard C; Department of Cardiovascular and Renal Research, Institute for Molecular Medicine, University of Southern Denmark, Odense, Denmark., Hansen MH; Department of Cardiovascular and Renal Research, Institute for Molecular Medicine, University of Southern Denmark, Odense, Denmark., Henriksen JE; Steno Diabetes Center Odense, Odense, Denmark., Jacobsen IA; Research Unit for Cardiovascular and Metabolic Prevention, Department of Endocrinology, Odense University Hospital, Odense, Denmark., Jensen BL; Department of Cardiovascular and Renal Research, Institute for Molecular Medicine, University of Southern Denmark, Odense, Denmark.

Publikováno v: American journal of physiology. Renal physiology [Am J Physiol Renal Physiol] 2024 Jul 01; Vol. 327 (1), pp. F37-F48. Date of Electronic Publication: 2024 May 23.

Impact of Prosigna test on adjuvant treatment decision in lymph node-negative early breast cancer-a prospective national multicentre study (EMIT-1).

Autor: Ohnstad HO; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo., Blix ES; Department of Oncology, University of North Norway, Tromsø; Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø., Akslen LA; Centre for Cancer Biomarkers CCBIO, Department of Clinical Medicine, Section for Pathology, University of Bergen, Bergen; Department of Pathology Haukeland University Hospital, Bergen., Gilje B; Department of Haematology and Oncology, Stavanger University Hospital, Stavanger., Raj SX; Department of Oncology, St Olavs Hospital, Trondheim., Skjerven H; Department of Breast Surgery, Vestre Viken Hospital Trust, Drammen., Borgen E; Department of Pathology, Division of Laboratory Medicine, Oslo University Hospital, Oslo., Janssen EAM; Department of Pathology, Stavanger University Hospital, Stavanger; Department of Chemistry, Bioscience and Environmental Engineering, Stavanger University, Stavanger, Norway; Menzies Health Institute Queensland and Griffith University, Southport, Australia., Mortensen E; Department of Pathology, University of North Norway, Tromsø., Brekke MB; Department of Pathology, St Olavs Hospital, Trondheim., Falk RS; Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Oslo., Schlichting E; Department of Oncology, Breast and Endocrine Surgery Unit, Division of Cancer Medicine, Oslo University Hospital, Oslo., Boge B; Department of Oncology, Hospital of Southern Norway, Kristiansand., Songe-Møller S; Department of Oncology, Østfold Hospital Trust, Kalnes., Olsson P; Department of Breast Surgery, Innlandet Hospital Trust, Hamar., Heie A; Department of Breast Surgery, Haukeland University Hospital, Bergen., Mannsåker B; Department of Oncology, Nordland Hospital, Bodø., Vestlid MA; Department of Breast Surgery, Telemark Hospital Trust, Skien., Kursetgjerde T; Department of Oncology, Møre og Romsdal Hospital Trust, Ålesund., Gravdehaug B; Department of Breast Surgery, Akershus University Hospital, Lørenskog., Suhrke P; Department of Pathology, Vestfold Hospital Trust, Tønsberg., Sanchez E; Department of Oncology, Haugesund Hospital, Haugesund., Bublevic J; Department of Oncology, Førde Central Hospital, Førde., Røe OD; Department of Oncology, Levanger Hospital, Levanger., Geitvik GA; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo., Halset EH; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo., Rypdal MC; Department of Pathology, Division of Laboratory Medicine, Oslo University Hospital, Oslo., Langerød A; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo., Lømo J; Department of Pathology, Division of Laboratory Medicine, Oslo University Hospital, Oslo., Garred Ø; Department of Pathology, Division of Laboratory Medicine, Oslo University Hospital, Oslo., Porojnicu A; Department of Oncology, Vestre Viken Hospital Trust, Drammen., Engebraaten O; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo; Institute of Clinical Medicine, University of Oslo, Oslo., Geisler J; Institute of Clinical Medicine, University of Oslo, Oslo; Department of Oncology, Akershus University Hospital, Lørenskog., Lyngra M; Department of Pathology, Akershus University Hospital, Lørenskog., Hansen MH; Department of Breast Surgery, University of North Norway, Tromsø., Søiland H; Department of Research, Stavanger University Hospital, Stavanger; Department of Clinical Science, University of Bergen, Bergen., Nakken T; User representative, Oslo University Hospital, Oslo., Asphaug L; Clinical Trials Unit, Oslo University Hospital, Oslo; Institute of Health and Society, Faculty of Medicine, University of Oslo, Oslo., Kristensen V; Institute of Clinical Medicine, University of Oslo, Oslo., Sørlie T; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo; Institute of Clinical Medicine, University of Oslo, Oslo., Nygård JF; Cancer Registry of Norway, Oslo., Kiserud CE; National Advisory Unit for Late Effects after Cancer Treatment, Oslo University Hospital, Oslo, Norway., Reinertsen KV; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo; National Advisory Unit for Late Effects after Cancer Treatment, Oslo University Hospital, Oslo, Norway., Russnes HG; Department of Pathology, Division of Laboratory Medicine, Oslo University Hospital, Oslo; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo; Institute of Clinical Medicine, University of Oslo, Oslo., Naume B; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo; Institute of Clinical Medicine, University of Oslo, Oslo. Electronic address: BNa@ous-hf.no.

Publikováno v: ESMO open [ESMO Open] 2024 Jun; Vol. 9 (6), pp. 103475. Date of Electronic Publication: 2024 Jun 04.